Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed Amendment No. 3 to Schedule 13G with the SEC on November 2, 2026, disclosing a combined beneficial ownership of 2,142,052 shares of RxSight, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Each of the three reporting persons disclosed beneficial ownership of 2,142,052 shares of RxSight, Inc. common stock, representing 5.1% of the class.
  • Below 5% threshold: According to the filing, "the reporting persons have ceased to beneficially own more than 5 percent of the class of securities."
  • No sole voting or dispositive power: All 2,142,052 shares are reported under shared voting power and shared dispositive power; sole voting and sole dispositive power are each listed as 0.00.
  • Triggering event date: The date of event requiring the filing is stated as September 30, 2026.
  • Reporting persons: Millennium Management LLC (Delaware), Millennium Group Management LLC (Delaware), and Israel A. Englander (United States) are all named filers, signing via a Joint Filing Agreement dated October 30, 2026.
  • CUSIP: The securities are identified by CUSIP number 78349D107, described as common stock with a par value of $0.001 per share.

Millennium's Schedule 13G Amendment for RxSight, Inc.

The filing, Amendment No. 3 to Schedule 13G, covers RxSight, Inc. (NASDAQ:RXST) common stock, par value $0.001 per share. According to the filing, each of Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander reports aggregate beneficial ownership of 2,142,052 shares as of the September 30, 2026 event date. The filing states that this position equals 5.1% of the class, and separately discloses that "the reporting persons have ceased to beneficially own more than 5 percent of the class of securities," indicating the stake fell to or below the 5% threshold at or around the event date.

The filing describes the structure of control: the securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC, which is the managing member of Millennium Management LLC. Mr. Englander is identified as the sole voting trustee of the managing member of Millennium Group Management LLC. The filing includes a disclaimer stating that this description "should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities."

All three reporting persons reported zero sole voting power and zero sole dispositive power over the shares. The filing was signed on October 30, 2026, by Gil Raviv as Global General Counsel on behalf of both Millennium entities, and separately by Israel A. Englander. A Joint Filing Agreement among the three parties, also dated October 30, 2026, is listed as Exhibit I. The filing certifies the securities were not acquired or held for the purpose of changing or influencing control of RxSight, Inc.

What Was Disclosed

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed Amendment No. 3 to Schedule 13G reporting 2,142,052 shares (5.1%) of RxSight, Inc. common stock as of September 30, 2026, and noting the group's beneficial ownership has fallen to 5% or less.